Abstract
Components of the metabolic syndrome (MetS) are involved in colorectal cancer development and the incidence of the disease is higher in obese and diabetic patients. Nevertheless, the value of these diseases or the MetS as a whole as prognostic markers once colorectal cancer is diagnosed is controversial.
Funding Information
  • Sault ste marie academic medical association

This publication has 18 references indexed in Scilit: